FDG-PET
Cross-source consensus on FDG-PET from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Benefits
Evidence quality
Highlighted claims
- FDG-PET measures cerebral glucose metabolism and is used as a complementary tool when FTD is clinically suspected. — Volumetric MRI and FDG-PET hypometabolism biomarkers of frontotemporal dementia: protocol for a systematic review and meta-analysis
- FDG-PET can reveal functional loss in regions that still appear structurally preserved on MRI. — Volumetric MRI and FDG-PET hypometabolism biomarkers of frontotemporal dementia: protocol for a systematic review and meta-analysis
- FDG-PET has not been established as reliable for differentiating tau from TDP-43 neuropathology. — Volumetric MRI and FDG-PET hypometabolism biomarkers of frontotemporal dementia: protocol for a systematic review and meta-analysis
- FDG-PET hypometabolism patterns can help discriminate between FTD syndromes such as bvFTD and PPA. — Volumetric MRI and FDG-PET hypometabolism biomarkers of frontotemporal dementia: protocol for a systematic review and meta-analysis